{"title":"Obesity as a risk factor for early-onset colorectal cancer: Evidence from a nationally representative database.","authors":"Omar Khattab, Mohamed Alharami, Frhaan Zahrawi, Ammar Hemaidan","doi":"10.5306/wjco.v16.i7.108220","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide with an alarming rise in early-onset CRC (eoCRC) over the past several decades. Unlike late-onset CRC, the drivers behind eoCRC remain less clear. While certain risk factors such as obesity and smoking have demonstrated a relatively strong association with eoCRC in the literature, some studies have challenged these associations, emphasizing the need for additional studies.</p><p><strong>Aim: </strong>To investigate the impact of various risk factors on eoCRC with a special focus on obesity.</p><p><strong>Methods: </strong>This cross-sectional study used de-identified data from the National Health and Nutrition Examination Survey (1999-2023), including 30321 United States adults aged 18 to 49 years. Participants with missing key variables were excluded. Standardized protocols were used to collect demographic, lifestyle, anthropometric [body mass index (BMI), body roundness index (BRI), waist circumference (WC)], and self-reported CRC data. Logistic regression and propensity score matching assessed associations between obesity-related parameters and eoCRC. Statistical analyses were performed in R and Stata, with <i>P</i> < 0.05 defined as significant.</p><p><strong>Results: </strong>Of 30321 participants, 48 received a diagnosis of eoCRC. Patients with eoCRC were older (mean age 39.96 years <i>vs</i> 34.36 years; <i>P</i> < 0.001) and had higher WC and BRI. None of the eoCRC patients were heavy drinkers (<i>P</i> = 0.006). Unadjusted models demonstrated significant associations of eoCRC with BRI quartiles, as well as BMI-defined obesity, WC, and smoking. In unadjusted models, BRI remained the strongest independent predictor; those in the highest BRI quartiles had over 10-fold greater odds of eoCRC. In fully adjusted models, BRI remained significant, but BMI- and waist-based obesity were not.</p><p><strong>Conclusion: </strong>BRI is a stronger predictor of eoCRC risk compared to other obesity indices and is a superior tool for identifying young individuals at higher risk of CRC.</p>","PeriodicalId":23802,"journal":{"name":"World journal of clinical oncology","volume":"16 7","pages":"108220"},"PeriodicalIF":3.2000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304983/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of clinical oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5306/wjco.v16.i7.108220","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide with an alarming rise in early-onset CRC (eoCRC) over the past several decades. Unlike late-onset CRC, the drivers behind eoCRC remain less clear. While certain risk factors such as obesity and smoking have demonstrated a relatively strong association with eoCRC in the literature, some studies have challenged these associations, emphasizing the need for additional studies.
Aim: To investigate the impact of various risk factors on eoCRC with a special focus on obesity.
Methods: This cross-sectional study used de-identified data from the National Health and Nutrition Examination Survey (1999-2023), including 30321 United States adults aged 18 to 49 years. Participants with missing key variables were excluded. Standardized protocols were used to collect demographic, lifestyle, anthropometric [body mass index (BMI), body roundness index (BRI), waist circumference (WC)], and self-reported CRC data. Logistic regression and propensity score matching assessed associations between obesity-related parameters and eoCRC. Statistical analyses were performed in R and Stata, with P < 0.05 defined as significant.
Results: Of 30321 participants, 48 received a diagnosis of eoCRC. Patients with eoCRC were older (mean age 39.96 years vs 34.36 years; P < 0.001) and had higher WC and BRI. None of the eoCRC patients were heavy drinkers (P = 0.006). Unadjusted models demonstrated significant associations of eoCRC with BRI quartiles, as well as BMI-defined obesity, WC, and smoking. In unadjusted models, BRI remained the strongest independent predictor; those in the highest BRI quartiles had over 10-fold greater odds of eoCRC. In fully adjusted models, BRI remained significant, but BMI- and waist-based obesity were not.
Conclusion: BRI is a stronger predictor of eoCRC risk compared to other obesity indices and is a superior tool for identifying young individuals at higher risk of CRC.
期刊介绍:
The WJCO is a high-quality, peer reviewed, open-access journal. The primary task of WJCO is to rapidly publish high-quality original articles, reviews, editorials, and case reports in the field of oncology. In order to promote productive academic communication, the peer review process for the WJCO is transparent; to this end, all published manuscripts are accompanied by the anonymized reviewers’ comments as well as the authors’ responses. The primary aims of the WJCO are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in oncology. Scope: Art of Oncology, Biology of Neoplasia, Breast Cancer, Cancer Prevention and Control, Cancer-Related Complications, Diagnosis in Oncology, Gastrointestinal Cancer, Genetic Testing For Cancer, Gynecologic Cancer, Head and Neck Cancer, Hematologic Malignancy, Lung Cancer, Melanoma, Molecular Oncology, Neurooncology, Palliative and Supportive Care, Pediatric Oncology, Surgical Oncology, Translational Oncology, and Urologic Oncology.